|
|
||||||||
Department of Nuclear Medicine, Rebecca Sieff Government Hospital, Safed, and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa; Department of Urology, Porya Government Hospital, Tiberia; Departments of Nuclear Medicine and Urology, Rambam Medical Center, Haifa, Israel
Correspondence: For reprints contact: Dr. David Groshar, Dept. of Nuclear Medicine, Rebecca Sieff Government Hospital, Safed, Israel 13100.
ABSTRACT
In an attempt to evaluate penile corporal venous outflow, a method that utilizes intracorporal injection of Tc-RBC was developed and used in 20 patients with erectile dysfunction. Seven patients showed venous leak and 13 had normal venous outflow. Technetium-labeled RBC corporal clearance in the flaccid state and after intracorporal injection of papaverine (30 mg) and regitine (1 mg) were assessed in sequence by two separate injections of 18.5 MBq of Tc-RBC each. The time for 50% corporal clearance (T50%) was determined from the time activity curves obtained in flaccid state and after intracorporal injection of the vasoactive agent. There were no statistically significant differences in T50% measured in the flaccid state between normal venous outflow (202 ± 139 sec) and venous leak (92 ± 35 sec, p = 0.1). However, after intracorporal injection of papaverine and regitine a significant increase in the T50% was noted in normal venous outflow (2892 ± 1899 sec) as compared to venous leak (213 ± 123 sec, p < 0.001). The results suggest that measurement of corporal clearance of Tc-RBC after intracorporal injection of papaverine may be a useful method in detecting venous leak, and could be used as a screening test in patients with erectile dysfunction.
This article has been cited by other articles:
![]() |
D Svasti-Salee, C J Wilkins, and P S Sidhu Imaging erectile dysfunction Imaging, October 1, 2005; 17(2): 113 - 121. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |